Results 1 to 7 of 7

Thread: Follow the stem cell money

  1. #1

    Follow the stem cell money

    Follow the stem cell money

    1 Comment
    Written by Lee Wishing
    October 18, 11:30 AM


    Earlier this month, Grove City College biology professors Dr. Jan Dudt and Dr. Durwood Ray attended the World Stem Cell Summit held in Detroit. I asked them about the summit and their observations.
    WISHING: What is the World Stem Cell Summit?

    DUDT: The World Stem Cell Summit is one of a number of annual gatherings of scientists and others working in the stem cell field. This one is not to be confused with another summit called the Stem Cell Summit.

    WISHING: How would you describe the difference between the two groups?

    DUDT: In simple terms, I’d say the Stem Cell Summit is investor-oriented with a focus on advances in adult stem cell research while the World Stem Cell Summit is researcher-oriented with a primary focus on embryonic stem cell research. Biotech investors do attend the World Stem Cell Summit, and this summit does touch on adult stem cell advances. As its name implies, the World Stem Cell Summit attracts people from all over the world. More than 1,000 people were in attendance this year.

    WISHING: What stood out to you?

    DUDT: There’s a growing gap between embryonic and adult stem cell research. The NFL is to adult stem cell research as peewee football is to embryonic stem cell research. Adult stem cell research is making tremendous advances while embryonic research seems to be still in the, well, embryonic phase. And the gap appears to be widening.

    RAY: Not only is the gap widening, but it’s widening in multiple areas such as muscle and tendon therapy, mammary cell research, pancreatic cell research, heart cell therapy, brain cell therapy, and much more.

    WISHING: What does this mean in practical terms?

    continue......

    http://online.worldmag.com/2010/10/1...em-cell-money/

  2. #2
    Senior Member
    Join Date
    Jan 2009
    Location
    Baldwinsville, N.Y.
    Posts
    647
    Manouli,
    Thanks for the updates. Money says it all. At least there is a lot of interests. Hopefully, we will see some positive results to get Wall Street involved. That will really get the wheels turning with progress.

  3. #3
    Why do you post this fucking christian bullshit propoganda? WAKE-UP, stop blindly posting.

    --- from the bullshit christian propaganda ---
    WISHING: Would you say the bottom line might provide some comfort to those of us who are opposed to embryonic stem cell research for ethical reasons?

    DUDT and RAY: Yes.

    ALSO
    We are dependent on God and independent of any political faction or interest group. We don't let advertisers influence news content. We don't print glorified press releases. We respect the office of president of the United States and submit to the ruling authorities instituted by God... blah blah blah
    ______
    Awe at my magnificent coq!

    "You may say I'm a dreamer
    but I'm not" - J. Lennon

  4. #4
    Senior Member 0xSquidy's Avatar
    Join Date
    Dec 2009
    Location
    Barcelona (Spain)
    Posts
    1,072
    We are dependent on God and [...] submit to the ruling authorities instituted by God... blah blah blah
    LOL

    This is just SICK
    Don't ask what clinical trials can do for you, ask what you can do for clinical trials.

    Fenexy: Proyecto Volver a Caminar

    http://www.fenexy.org (soon in english too)

  5. #5
    The military is putting money into all therapies. SOCOM in particular is NOT limiting its interest.

  6. #6
    manouli,

    Thanks for posting this. As I have attended and spoken at every World Stem Cell Summit and almost every Stem Cell Summit (in New York) from the beginning, I feel qualified to make the comparison.

    The difference between the World Stem Cell Summit (WSCS) and the Stem Cell Summit (SCS) is that the former is a meeting for stem cell advocates and the latter is a meeting for industry and investors. Both meetings ask scientists to come and present the latest cutting edge research. Both meetings have scientists, advocates, investors, and industry representatives but the focus of WSCS is advocacy while the focus of SCS is investment.

    The stem cell industry is still fledgling. The first company to make money and get a new stem cell product approved by the FDA is Osiris, funded by Genzyme. They are using mesenchymal stem cells called Prochymal to treat graft-versus-host-disease. It is true that adult stem cells are the first to reach the market (Source).

    On the other hand, studies of embryonic stem cells have now led to the discovery of induced pluripotent stem (IPS) cells that will be the future of regenerative medicine. We now know the genes that are responsible for pluripotency and should be able to convert any cell into a stem cell.

    It is so sad that there are people who are interested in using politics to shut down research. The concept that studying embryonic stem cells is killing or will kill babies is a lie. With the advent of IPS cells, there is no danger of a slippery slope towards harvesting of embryos for therapeutic purposes. This danger was never real.

    IPS cells have blurred the lines between adult and embryonic. However, we cannot really understand IPS cells unless scientists are allowed to study embryonic stem cells. This is where the people who have continued to oppose embryonic stem cell research have done society and the world a true disfavor. If we were forbidden to study embryonic stem cells, we would never have found the genes that made stem cells pluripotent.

    If our government continues to restrict embryonic research and funding of such research, the United States will fall seriously behind other countries. It was no accident that the genes for IPS cells were discovered in Kyoto. It is also no accident that the most important studies regarding stem cells are still coming from overseas. While California is catching up due to a $3 billion bond passed by the people of California, the rest of the United States is falling behind in stem cell research.

    Perhaps we shouldn't care which country the stem cell advances are coming from, as long as progress is being made. However, if stem cell research in the United States were unleashed and adequately funded, the research would proceed much more rapidly. The NIH, which funds a majority of biomedical research in universities across the country, is funding less stem cell research (adult or embryonic) than California.

    Both the World Stem Cell Summit and the Stem Cell Summit play very important roles in the field, one of the reasons why I go to both meetings every year, despite my busy schedule. Advocates must not stop pressing and industry must continue to find profitable business models for regenerative medicine.

    Wise.













    Quote Originally Posted by manouli View Post
    Follow the stem cell money

    1 Comment
    Written by Lee Wishing
    October 18, 11:30 AM


    Earlier this month, Grove City College biology professors Dr. Jan Dudt and Dr. Durwood Ray attended the World Stem Cell Summit held in Detroit. I asked them about the summit and their observations.
    WISHING: What is the World Stem Cell Summit?

    DUDT: The World Stem Cell Summit is one of a number of annual gatherings of scientists and others working in the stem cell field. This one is not to be confused with another summit called the Stem Cell Summit.

    WISHING: How would you describe the difference between the two groups?

    DUDT: In simple terms, I’d say the Stem Cell Summit is investor-oriented with a focus on advances in adult stem cell research while the World Stem Cell Summit is researcher-oriented with a primary focus on embryonic stem cell research. Biotech investors do attend the World Stem Cell Summit, and this summit does touch on adult stem cell advances. As its name implies, the World Stem Cell Summit attracts people from all over the world. More than 1,000 people were in attendance this year.

    WISHING: What stood out to you?

    DUDT: There’s a growing gap between embryonic and adult stem cell research. The NFL is to adult stem cell research as peewee football is to embryonic stem cell research. Adult stem cell research is making tremendous advances while embryonic research seems to be still in the, well, embryonic phase. And the gap appears to be widening.

    RAY: Not only is the gap widening, but it’s widening in multiple areas such as muscle and tendon therapy, mammary cell research, pancreatic cell research, heart cell therapy, brain cell therapy, and much more.

    WISHING: What does this mean in practical terms?

    continue......

    http://online.worldmag.com/2010/10/1...em-cell-money/
    Last edited by Wise Young; 10-19-2010 at 03:22 PM.

  7. #7
    wise, the key to what you've posted is that the USA will fall behind the rest of the world in research and vialbe therapies. The fruitless and baseless oposition to enbryonic stem cell research is nothing more tha a olitical football by those who have no real agendas for the betterment of human life. Judge Lambro is a perfect example of a do nothing judge . the republican oposition to the research is of course just a poitical stance to interrupt those who have goals of betterment of human beings. If the rest of the world gains ahead of the USA, then so be it.

Similar Threads

  1. Brain Experts Now Follow the Money
    By antiquity in forum Health & Science News
    Replies: 0
    Last Post: 06-16-2003, 10:07 PM
  2. Follow the money!
    By Cris in forum Life
    Replies: 2
    Last Post: 04-14-2003, 02:51 PM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •